Management of post-traumatic stress disorder

Management of post-traumatic stress disorder refers to the evidence-based therapeutic and pharmacological interventions aimed at reducing symptoms of post-traumatic stress disorder (PTSD) and improving the quality of life for individuals affected by it. Effective approaches include trauma-focused psychotherapy as a first-line treatment, with options such as cognitive behavioral therapy (CBT), prolonged exposure therapy, and cognitive processing therapy (CPT) demonstrating strong evidence for reducing PTSD symptoms.

Pharmacological treatments primarily involve selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), and a few symptom-specific medications, such as prazosin for sleep disturbances. Experimental treatments like psychedelics are under investigation. Complementary therapies including yoga, acupuncture, and animal-assisted interventions can provide additional support for some individuals.

Guidelines from organizations such as the American Psychological Association and the National Institute for Health and Care Excellence inform treatment strategies, emphasizing the importance of personalized care. Challenges such as comorbid conditions and the need for culturally adapted interventions highlight the complexity of PTSD management. Innovative approaches including rTMS therapy and digital interventions such as PTSD Coach and virtual reality exposure therapy are expanding access to care and further diversifying treatment options.